The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 01, 2016
Filed:
Apr. 17, 2014
Applicant:
Genzyme Corporation, Cambridge, MA (US);
Inventors:
Oxana Ibraghimov-Beskrovnaya, Southborough, MA (US);
Thomas A. Natoli, Revere, MA (US);
Assignee:
Genzyme Corporation, Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01); A61K 31/445 (2006.01); A61K 31/425 (2006.01); A61K 31/40 (2006.01); C07D 417/14 (2006.01); A61K 31/325 (2006.01); A61K 31/357 (2006.01); A61K 31/396 (2006.01); A61K 31/4025 (2006.01); A61K 31/403 (2006.01); A61K 31/4155 (2006.01); A61K 31/4178 (2006.01); A61K 31/4192 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/4433 (2006.01); A61K 31/4439 (2006.01); A61K 31/453 (2006.01); A61K 31/4725 (2006.01); A61K 31/5377 (2006.01); C07D 207/06 (2006.01); C07D 319/16 (2006.01); C07D 405/10 (2006.01); C07D 405/14 (2006.01); C07D 319/18 (2006.01); C07D 405/06 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/325 (2013.01); A61K 31/357 (2013.01); A61K 31/396 (2013.01); A61K 31/40 (2013.01); A61K 31/403 (2013.01); A61K 31/4025 (2013.01); A61K 31/4155 (2013.01); A61K 31/4178 (2013.01); A61K 31/4192 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/4433 (2013.01); A61K 31/4439 (2013.01); A61K 31/453 (2013.01); A61K 31/4725 (2013.01); A61K 31/5377 (2013.01); C07D 207/06 (2013.01); C07D 319/16 (2013.01); C07D 319/18 (2013.01); C07D 405/06 (2013.01); C07D 405/10 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01);
Abstract
A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor.